Summary
- Profile Type
- Business Offer
- POD Reference
- BOGR20230517009
- Term of Validity
- 17 May 2023 - 16 May 2025
- Company's Country
- Greece
- Type of partnership
- Investment agreement
- Targeted Countries
- All countries
Contact the EEN partner nearest to you for more information.
Find my local partner
General information
- Short Summary
- A dynamic Greek start-up with expertise in producing medical cannabis and excellent cultivation facilities is looking for investors to scale up its production capacity.
- Full Description
-
This is a medical cannabis production and trading company based in Greece, focused on creating and commercialising ultra-premium cannabis products with an emphasis on quality and sustainability.
The client is currently developing an indoor state-of-the art cannabis cultivation and processing facility, which is certified according to EU good manufacturing practice (GMP) standards. This is the minimum standard that a manufacturer of medicines must meet in their production processes, in compliance with European Medicines Agency stipulations.
The company has its own originally-labelled iconic products, as well as access to an important portfolio of US cannabis brands through its existing collaboration with US partners.
The company has already established a sophisticated facility, which gives tremendous acceleration in the time of market penetration. It is strategically structured in such a way that allows it to develop market-ready products very quickly and efficiently with an emphasis on quality and innovation. This is made possible not only by the design of its facility and its current state and technology, but also from the already market-tested products sourced from a broad genetic stock of more than 150 strains of proven popular varieties.
It is ready to engage in a range of cannabis-related activities including: niche market high-end indoor cultivation, genetics stabilization, product research and development, manufacturing of local and infused products, and clone production.
It has already set up the comprehensive infrastructure necessary for sustained success (including official licenses, know-how, experience, budget management-control-strategy, distribution pre-agreements, a network of key contacts within Greece, etc.).
The client is urgently seeking potential investors to provide financial backing for a further boost to its production capacity. - Advantages and Innovations
-
There are a number of possible benefits for potential investors, including:-
1. Investing in a cultivation facility that will accelerate the time to harvest under EU good manufacturing practice (GMP) standards. The unit includes genetic stabilization as well as an impressive array of research and product development activities.
2. Cultivation capacity of up to 5 tons of premium pharmaceutical-grade indoor quality cannabis, which can be sold mainly in its premium flower form.
3. Addition scope for investing in a light-deprivation greenhouse – this is a technique used whereby the greenhouse can be covered to block out sunlight, which shortens the daily light cycle, thus forcing cannabis plants to flower early. This would result in the possibility of growing up to 3 additional tons of quality cannabis, giving a total capacity of 8 tons of premium cannabis. - Stage of Development
- Under development
- Sustainable Development Goals
- Goal 3: Good Health and Well-being
Partner Sought
- Expected Role of a Partner
- The client is urgently seeking potential investors to provide financial backing for a further boost to its production capacity. Existing knowledge of the cannabis / pharmaceuticals market would be a bonus but is not pre-requisite to co-operation.
- Type and Size of Partner
- SME <=10
- Other
- Type of partnership
- Investment agreement
Dissemination
- Technology keywords
- 06001015 - Pharmaceutical Products / Drugs
- Market keywords
- 05007002 - Pharmaceuticals/fine chemicals
- Sector Groups Involved
- Health
- Targeted countries
- All countries
